CN1879842A - A Chinese medicine for treating cancer - Google Patents
A Chinese medicine for treating cancer Download PDFInfo
- Publication number
- CN1879842A CN1879842A CN 200610012736 CN200610012736A CN1879842A CN 1879842 A CN1879842 A CN 1879842A CN 200610012736 CN200610012736 CN 200610012736 CN 200610012736 A CN200610012736 A CN 200610012736A CN 1879842 A CN1879842 A CN 1879842A
- Authority
- CN
- China
- Prior art keywords
- parts
- chinese medicine
- tumor
- cattle
- rhizoma curcumae
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention provides a Chinese medicament for treating tumor, which is prepared from the following raw materials (by weight ratio): cow-bezoar 6-15 parts, subprostrate sophora root 6-15 parts, bulb of edible tulip 3-6 parts, rhizoma zedoariae 10-15 parts, and ganoderma lucidum 10-20 parts.
Description
Technical field
The invention belongs to a kind of medicine for the treatment of tumor, specifically is the Chinese drugs agentia of feedstock production with the Chinese herbal medicine.
Background technology
Tumor is a disease that is difficult to treat at the clinical medicine category, and prior treatment method adopts excision mostly, carries out the method for chemotherapy again.Above-mentioned treatment brings very big misery to the patient, but is difficult to reach healing.Numerous medical personnels are at the effective ways of studying intensively, seek treatment, but the present medicament that does not also have effectively to cure tumor.
Summary of the invention
Of the present inventionly provide a kind of Chinese medicine for the treatment of tumor, the effectively growth of anticancer prevents that effectively tumor from shifting and recurrence, reaches the purpose of healing.
Medicine of the present invention is formed (consumption is a weight portion) by following component:
The other sub-6-15 part of cattle, Radix Sophorae Tonkinensis 6-15 part, Pseudobulbus Cremastrae Seu Pleiones 3-6 part, Rhizoma Curcumae 10-15 part, Ganoderma 10-20 part.
The formula optimization weight proportion scope of preparation medicine of the present invention is:
The other sub-8-13 part of cattle, Radix Sophorae Tonkinensis 8-14 part, Pseudobulbus Cremastrae Seu Pleiones 4-5 part, Rhizoma Curcumae 11-13 part, Ganoderma 13-16 part.
The optimum weight proportioning of medicine of the present invention is:
10 parts of other sons, 10 parts of Radix Sophorae Tonkinensiss, 5 parts of Pseudobulbus Cremastrae Seu Pleioness, 12 parts of Rhizoma Curcumae, 15 parts of Ganodermas.
Pharmacology analysis:
The other son of cattle: contain by the cattle, fatty oil, vitamin A, vitamin B and alkaloid etc.The other sub-decoct of cattle has analgesic diuretic actions; The other son of recent findings cattle has antitumor action; Its crude extract is selection toxicity, and low amount just can be bred by anticancer, makes tumor cell approaching to normal cell.
Radix Sophorae Tonkinensis: contain matrine, oxymatrine, bean curd with odor and methylcytisine also contain multiple flavone compound in addition, as pterocarpin, red east axle grass etc.Root of subprostrate sophora has antitumaous effect, and contained oxymatrine all is inhibitory action to 180 yoshida sarcomas, ascites hepatocarcinoma tumor.
Pseudobulbus Cremastrae Seu Pleiones: the mucous and glucose of Cuculus polioephalus rhizome is joined the mannitol polysaccharide.Synthetic NSC-3096 behind contained autumn waters--limid eyes alkali of Pseudobulbus Cremastrae Seu Pleiones Tulipa edulis and iphigenia indica and the adding ammonia thereof all has the antitumor action similar to vinblastine.
Rhizoma Curcumae contains volatile oil, wherein mainly is the Rhizoma Curcumae paulownia, curzerene, curcumin etc., and isolating the two alcohol of anticancer main component curcumenol, Rhizoma Curcumae from volatile oil has antitumaous effect, also can make the place live specific immune function and strengthen, and obtains tangible immunoprotection effect.
Ganoderma: also have selenic composition in the Ganoderma, selenium kills tumor and can not hurt sb.'s feelings, and through evidence, selenium is not only stared at and killed fixed tumor cell, but also can remove free tumor cell in the blood, the transfer and the recurrence of having stopped tumor everywhere.
Said herbal medicine according to formula compatibility of the present invention, can be played the anticancer growth, and the transfer and the recurrence of stopping cancerous cell are stared at and are killed fixed tumor cell, thereby cure cancer.
The specific embodiment
After medicine of the present invention makes according to set of dispense, can take by fried according to a conventional method one-tenth decoction, also can manufacture the Chinese medicine pill according to a conventional method, the Chinese medicine electuary is taken, can also daily dosage effective component extracting according to Chinese herbal medicine after, make capsule and quantitatively take on time.
The present invention takes medicine one week of back through clinical practice, and tumor is obviously dwindled, and expands to suppress pain and obviously reduce, and then goes down day by day, decides on state of an illness weight, and there are positive effect or healing 10-30 day.Adopt prescription treatment cancerous protuberance 30 examples of the present invention, cure rate 58%, effective percentage are imitated and are reached 90%.
Model case: Lee * *, the woman, 40 years old, to suffer from the lymph node tumor in July, 2003 and done to recur again after the operation, tuberosity appears again in cervical region.Take the fried decoction of Chinese medicine of the present invention, one day twice, sooner or later service once, lump dwindles after 3 days, and whole body has comfortable sensation; Tumor disappears after taking medicine 7.Observe year nothing recurrence half a year to one continuously.
Claims (3)
1, a kind of Chinese medicine for the treatment of tumor is characterized in that it is the medicament of being made by the following weight proportion raw material: the other sub-6-15 part of cattle, Radix Sophorae Tonkinensis 6-15 part, Pseudobulbus Cremastrae Seu Pleiones 3-6 part, Rhizoma Curcumae 10-15 part, Ganoderma 10-20 part.
2, the Chinese medicine of treatment tumor according to claim 1 is characterized in that: wherein the weight proportion of each raw material is: the other sub-8-13 part of cattle, Radix Sophorae Tonkinensis 8-14 part, Pseudobulbus Cremastrae Seu Pleiones 4-5 part, Rhizoma Curcumae 11-13 part, Ganoderma 13-16 part.
3, the Chinese medicine of treatment tumor according to claim 1 is characterized in that: wherein the weight proportion of each raw material is: 10 parts of the other sons of cattle, 10 parts of Radix Sophorae Tonkinensiss, 5 parts of Pseudobulbus Cremastrae Seu Pleioness, 12 parts of Rhizoma Curcumae, 15 parts of Ganodermas.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2006100127366A CN100455322C (en) | 2006-05-17 | 2006-05-17 | A Chinese medicine for treating cancer |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2006100127366A CN100455322C (en) | 2006-05-17 | 2006-05-17 | A Chinese medicine for treating cancer |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1879842A true CN1879842A (en) | 2006-12-20 |
CN100455322C CN100455322C (en) | 2009-01-28 |
Family
ID=37518343
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB2006100127366A Expired - Fee Related CN100455322C (en) | 2006-05-17 | 2006-05-17 | A Chinese medicine for treating cancer |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN100455322C (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102266434A (en) * | 2011-08-05 | 2011-12-07 | 暨南大学 | Chinese medicinal composition for resisting tumor metastasis and preparation method thereof |
CN108379508A (en) * | 2018-03-15 | 2018-08-10 | 陆海燕 | A kind of composition that treating tumour and its preparation and application and application |
CN108619452A (en) * | 2018-05-18 | 2018-10-09 | 杜美丽 | It a kind of Chinese medicine composition that treating tumour and follows through permeabilization therapy |
CN111184815A (en) * | 2020-02-24 | 2020-05-22 | 杭州憶盛医疗科技有限公司 | Anti-tumor injection for treating lymphosarcoma and preparation method thereof |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1250275C (en) * | 2002-09-19 | 2006-04-12 | 于天德 | Traditional Chinese medicine for treating cancer and preparation method thereof |
-
2006
- 2006-05-17 CN CNB2006100127366A patent/CN100455322C/en not_active Expired - Fee Related
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102266434A (en) * | 2011-08-05 | 2011-12-07 | 暨南大学 | Chinese medicinal composition for resisting tumor metastasis and preparation method thereof |
CN102266434B (en) * | 2011-08-05 | 2013-04-10 | 暨南大学 | Chinese medicinal composition for resisting tumor metastasis and preparation method thereof |
CN108379508A (en) * | 2018-03-15 | 2018-08-10 | 陆海燕 | A kind of composition that treating tumour and its preparation and application and application |
CN108619452A (en) * | 2018-05-18 | 2018-10-09 | 杜美丽 | It a kind of Chinese medicine composition that treating tumour and follows through permeabilization therapy |
CN111184815A (en) * | 2020-02-24 | 2020-05-22 | 杭州憶盛医疗科技有限公司 | Anti-tumor injection for treating lymphosarcoma and preparation method thereof |
Also Published As
Publication number | Publication date |
---|---|
CN100455322C (en) | 2009-01-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR20080057368A (en) | A composition comprising the extract of complex herb improving liver cirrhosis, cytotoxicity and liver injury for preventing and treating of liver disease | |
CN102727706A (en) | Composition for preventing and treating diabetes | |
CN101856384B (en) | Liver-protecting combination | |
KR101826737B1 (en) | A composition containing herbs extract, and manufacturing method of the same | |
CN100455322C (en) | A Chinese medicine for treating cancer | |
CN103041042A (en) | Tibetan medicine composition and application of composition in anti-off hair products | |
US20060024391A1 (en) | Dietary nutritional suppliments for persons smoking tobacco products | |
CN103238757B (en) | Compound feed containing fermented cottonseed meal for chicken for eggs and preparation method thereof | |
Choudhary et al. | Wheatgrass (Triticum aestivum Linn.): a potential substitute of human blood in traditional system of medicine | |
CN104489172A (en) | Acanthopanax health tea for improving immunity and preparation method thereof | |
WO2023125797A1 (en) | Traditional chinese medicine composition and preparation method and application thereof | |
CN105030858A (en) | Cynomorium songaricum healthcare tablet and preparation method thereof | |
Upendra et al. | Healthcare prominence and immune boosting activity of ashwagandha against various clinical conditions and covid 19 disease outbreak | |
CN102631518B (en) | New medicament for treating leukemia | |
CN101584750B (en) | Compound fig preparation | |
CN102742828A (en) | Dietetic therapy product for protecting prostate and preparation method thereof | |
CN105169149A (en) | Traditional Chinese medicine composition for treating pyrophlegm stasis accumulation type thyroid cancer, preparation method and application | |
CN104800317A (en) | Chinese medicinal composition for preventing and treating chicken coccidiosis and preparation method | |
CN104491677A (en) | Preparation method of medicament for treating sexual dysfunction | |
CN102178221B (en) | Cordyceps militaris composite nutrition composition capable of improving defecation function and preparation method thereof | |
CN100340232C (en) | Jinshu leaf styptic mixture and its preparing method and use | |
KR102675725B1 (en) | Herbal pill composition for anti-inflammatory and immune enhancement containing Paeonia lactiflora and Cinnamomum cassia Blume and its preparation method | |
CN102648956A (en) | Traditional Chinese herbal medicament for treating breast cancer and preparation method thereof | |
KR101307726B1 (en) | A composition comprising the extract of Angelica dahurica for preventing and treating drug intoxication or withdrawal symptoms | |
CN100425255C (en) | Medicine for treating cervical disease and its preparation method |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C17 | Cessation of patent right | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20090128 Termination date: 20140517 |